Search for Clinical Trials
This is a randomized, double-blind, placebo-controlled, parallel-group study to verify the clinical benefit of aducanumab (BIIB037) in participants…
This research study will test the effectiveness of an oral medication, semaglutide, in slowing cognitive decline in people with early Alzheimer’s…
A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment with BAN2401 in Subjects with…
A randomized double-blind placebo-controlled phase 2 study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of…
Introduction:
The melanocortin-4 receptor (MC4R) pathway is the principal regulator of mammalian energy balance and body weight. Originating in the…
Essential Tremor: A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled study of botox for the treatment of upper limb essential tremor…
Cerevel has begun a study of an investigational drug called CVL-751 (also known as Tavapadon) as a possible treatment for Parkinson's disease. An…
The Study:
Along with our research partners at Quadrant Biosciences and Autism Speaks, we are looking for children who present signs of being on the…
A randomized, placebo-controlled, double-blind study to evaluate the effect of Sage-718 on cognitive function in participants with Huntington's…
A comparative study of Levodopa and Carbidopa bioavailability following Foslevodopa/Foscarbidopa infusion at different subcutaneous sites in…
